MYELIN DEGRADING ACTIVITY IN THE CSF OF HIV-1-INFECTED PATIENTS WITH NEUROLOGICAL DISEASES

被引:14
|
作者
LIUZZI, GM
MASTROIANNI, CM
FANELLI, M
MASSETTI, AP
VULLO, V
DELIA, S
RICCIO, P
机构
[1] UNIV BARI,DEPT BIOCHEM & MOLEC BIOL,I-70126 BARI,ITALY
[2] CNR,CTR STUDY MITOCHONDRIA & ENERGET METAB,I-70126 BARI,ITALY
[3] UNIV BARI,INST HYG,CHAIR MED STAT,BARI,ITALY
[4] UNIV ROMA LA SAPIENZA,DEPT INFECT & TROP DIS,ROME,ITALY
关键词
PROTEASES; MYELIN BASIC PROTEIN; DEMYELINATION; CEREBROSPINAL FLUID; AIDS DEMENTIA COMPLEX; PML; TOXOPLASMOSIS; HIV-1;
D O I
10.1097/00001756-199412300-00040
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
DEGRADATION of purified myelin basic protein (MBP) was studied by SDS gel electrophoresis after addition of CSF samples obtained from HIV-1-infected patients. An increase in MBP degradation was detected in patients with neurological complications, such as AIDS dementia complex (ADC) or progressive multifocal leukoencephalopathy (PML), when compared with patients with no neurological symptoms (NA) or with other neurological opportunistic infections (OI). In the ADC and PML patients, in addition to CSF proteolytic activity, an increase in CSF-MBP levels and presence of white matter lesions were also observed by neuroimaging (MRI). In other opportunistic infections of the brain, MBP levels but not anti-MBP proteolytic activity increased. Results suggest the involvement of proteases in the virus-induced demyelination.
引用
收藏
页码:157 / 160
页数:4
相关论文
共 50 条
  • [41] Myelopathy in a previously asymptomatic HIV-1-infected patient
    Eyer-Silva, WA
    Auto, I
    Pinto, JFC
    Morais-de-Sá, CA
    INFECTION, 2001, 29 (02) : 99 - 102
  • [42] Disease Progression in HIV-1-Infected Viremic Controllers
    Groves, Katherine C.
    Bibby, David F.
    Clark, Duncan A.
    Isaksen, Are
    Deayton, Jane R.
    Anderson, Jane
    Orkin, Chloe
    Stagg, Andrew J.
    McKnight, Aine
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 61 (04) : 407 - 416
  • [43] Proviral HIV-1 DNA in gingival crevicular fluid of HIV-1-infected patients in various stages of HIV disease
    Maticic, M
    Poljak, M
    Kramar, B
    Tomazic, J
    Vidmar, L
    Zakotnik, B
    Skaleric, U
    JOURNAL OF DENTAL RESEARCH, 2000, 79 (07) : 1496 - 1501
  • [44] Plasma HIV RNA level is associated with neurocognitive function among HIV-1-infected patients in Nigeria
    Jumare, Jibreel
    El-Kamary, Samer S.
    Magder, Laurence
    Hungerford, Laura
    Ndembi, Nicaise
    Aliyu, Ahmad
    Dakum, Patrick
    Umlauf, Anya
    Cherner, Mariana
    Abimiku, Alash'le
    Charurat, Man
    Blattner, William A.
    Royal, Walter, III
    JOURNAL OF NEUROVIROLOGY, 2018, 24 (06) : 712 - 719
  • [45] Insulin resistance is associated with cognition among HIV-1-infected patients - The Hawaii aging with HIV cohort
    Valcour, Victor G.
    Sacktor, Ned C.
    Paul, Robert H.
    Watters, Michael R.
    Selnes, Ola A.
    Shiramizu, Bruce T.
    Williams, Andrew E.
    Shikuma, Cecilia M.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 43 (04) : 405 - 410
  • [46] CSF CHANGES IN A LONGITUDINAL-STUDY OF 124 NEUROLOGICALLY NORMAL HIV-1-INFECTED UNITED-STATES AIR-FORCE PERSONNEL
    MARSHALL, DW
    BREY, RL
    BUTZIN, CA
    LUCEY, DR
    ABBADESSA, SM
    BOSWELL, RN
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1991, 4 (08): : 777 - 781
  • [47] Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy
    Yilmaz, Aylin
    Price, Richard W.
    Spudich, Serena
    Fuchs, Dietmar
    Hagberg, Lars
    Gisslen, Magnus
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 47 (02) : 168 - 173
  • [48] DETERMINATION OF VIRAL TROPISM BY GENOTYPING AND PHENOTYPING ASSAYS IN BRAZILIAN HIV-1-INFECTED PATIENTS
    Arruda, Lia Barbara
    de Araujo, Marilia Ladeira
    Martinez, Maira Luccia
    Gonsalez, Claudio Roberto
    da Silva Duarte, Alberto Jose
    Coakley, Eoin
    Lie, Yolanda
    Casseb, Jorge
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2014, 56 (04): : 287 - 290
  • [49] Evaluation of the effect of protective genetic variants on cART success in HIV-1-infected patients
    Lori, E. M.
    Cozzi-Lepri, A.
    Tavelli, A.
    Mercurio, V.
    Ibba, S. V.
    Lo Caputo, S.
    Castelli, F.
    Castagna, A.
    Gori, A.
    Marchetti, G.
    Venditti, C.
    Clerici, M.
    Monforte, A. D'Arminio
    Biasin, M.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (04): : 1553 - 1559
  • [50] Plasma and saliva concentrations of abacavir, tenofovir, darunavir, and raltegravir in HIV-1-infected patients
    Yamada, Eiko
    Takagi, Ritsuo
    Tanabe, Yoshinari
    Fujiwara, Hiroshi
    Hasegawa, Naoki
    Kato, Shingo
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (07) : 567 - 570